The European Commission and the Canadian Institutes for Health Research announced over $12M in funding to expand SFU’s iReceptor initiative.
iReceptor is a newly developed platform for managing massive repositories of worldwide distributed data that researchers can securely access in their quest to develop new therapies for autoimmune and infectious diseases, and cancer.
Felix Breden, iReceptor’s scientific director and a professor of biological sciences, says the undertaking is a prime example of how integrating data across multiple studies and institutions is critical to health research.
“Think of it as an enormous data repository that holds the millions of patterns of responses that the immune system uses to fight disease and infection,” he says.
Read the full article at sfu.ca/sfunews